← All organizations

Erydel

For profitWebsite ↗

Also known as: Erydel | EryDel S.p.A

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 30, 2018

Acquired by Quince Therapeutics on Aug 17, 2023

Timeline

2000s

Feb 1, 2007
Erydel— Founded

2020s

Aug 17, 2023
Quince Therapeutics— Acquired By

Drugs by trial phase (2 distinct, 6 trials)

Phase 3 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

NCT03563053Lead sponsorPhase 3Jun 30, 2018
NCT02770807Lead sponsorPhase 3Mar 2, 2017
NCT02770807Study directorPhase 3Mar 2, 2017
NCT02380924Lead sponsorPhase 1Jan 1, 2015
NCT01925859Lead sponsorPhase 1Jun 1, 2013
NCT01255358Lead sponsorPhase 2Feb 1, 2011
NCT01277289Lead sponsorPhase 3Apr 1, 2009

Details

Founded: San Giovanni, IT Feb 1, 2007
Last known activity: Jun 30, 2018